Back

Identification of SPP1-positive macrophages by single-cell spatial analysis in human lung tissues with mycobacterial infection

Katano, H.; Hebisawa, A.; Sato, Y.; Hoshino, Y.

2024-09-18 pathology
10.1101/2024.09.12.612778 bioRxiv
Show abstract

Tuberculosis and non-tuberculous mycobacterial (NTM) diseases are infections caused by Mycobacterium tuberculosis and non-tuberculous mycobacteria such as the Mycobacterium avium complex, leading to the formation of granulomatous lesions with caseous necrosis in the lungs. Although granulomatous tissues are infiltrated by numerous inflammatory cells, including macrophages, lymphocytes, and neutrophils, the mechanisms underlying granuloma formation caused by mycobacteria remain unclear. In this study, we performed single-cell spatial analysis on lung tissue samples from patients with tuberculosis and NTM diseases to investigate the infiltrating cell populations. We analyzed seven lung lesions and identified individual cell types infiltrating the granulomatous tissue. Based on gene expression profiles, at least four macrophage subtypes were identified. Notably, SPP1-positive macrophages predominantly found infiltrating the granulomatous tissue. Langhans giant cells expressed SPP1, and numerous SPP1-positive macrophages without giant cell morphology were also observed around the granulomas. RNA-seq analysis revealed elevated SPP1 expression in mycobacterium-infected tissues. The SPP1-CD44 signaling pathway was active in SPP1-positive macrophages and their neighboring cells in mycobacterium-infected tissues. SPP1-positive macrophages were also observed around granulomas in other granulomatous diseases, such as granulomatosis with polyangiitis and sarcoidosis. These findings suggest that SPP1-CD44 signaling in SPP1-positive macrophages may play a role in the pathology of granulomatous diseases, including mycobacterial infections. Brief summarySPP1-CD44 signaling in SPP1-positive macrophages may play a role in granuloma formation in mycobacterial and other granulomatous diseases.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Tuberculosis
11 papers in training set
Top 0.1%
41.6%
2
PLOS Pathogens
721 papers in training set
Top 2%
9.7%
50% of probability mass above
3
Frontiers in Immunology
586 papers in training set
Top 2%
4.4%
4
PLOS ONE
4510 papers in training set
Top 44%
2.7%
5
European Respiratory Journal
54 papers in training set
Top 0.7%
2.2%
6
EBioMedicine
39 papers in training set
Top 0.2%
2.2%
7
Scientific Reports
3102 papers in training set
Top 52%
2.0%
8
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.4%
2.0%
9
The Journal of Infectious Diseases
182 papers in training set
Top 2%
2.0%
10
Respiratory Research
19 papers in training set
Top 0.2%
1.8%
11
The Journal of Immunology
146 papers in training set
Top 0.9%
1.6%
12
Frontiers in Microbiology
375 papers in training set
Top 6%
1.4%
13
mBio
750 papers in training set
Top 8%
1.4%
14
eLife
5422 papers in training set
Top 48%
1.3%
15
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.7%
0.8%
16
Microbiology Spectrum
435 papers in training set
Top 5%
0.8%
17
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.8%
0.8%
18
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 5%
0.8%
19
Journal of Infection
71 papers in training set
Top 3%
0.8%
20
Pathogens
53 papers in training set
Top 1%
0.8%
21
Communications Biology
886 papers in training set
Top 21%
0.8%
22
Journal of Clinical Microbiology
120 papers in training set
Top 2%
0.8%
23
European Journal of Immunology
57 papers in training set
Top 0.6%
0.7%
24
BMC Infectious Diseases
118 papers in training set
Top 6%
0.7%
25
Arthritis Research & Therapy
15 papers in training set
Top 0.3%
0.7%
26
Clinical Immunology
21 papers in training set
Top 0.7%
0.7%
27
iScience
1063 papers in training set
Top 39%
0.5%
28
International Immunopharmacology
15 papers in training set
Top 0.7%
0.5%